COL1A1 and neoplasm: In the OHS xenograft model, 24 hours after intravenous administration of 125I-labeled mAbs TP-1 and TP-3 [34, 50], tumor to normal tissue ratios were comparable to the ratios found for the OI-3 mAbs labeled with 125I in this study.